These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 26706175)

  • 1. A minimally cytotoxic CD4 mimic as an HIV entry inhibitor.
    Mizuguchi T; Harada S; Miura T; Ohashi N; Narumi T; Mori H; Irahara Y; Yamada Y; Nomura W; Matsushita S; Yoshimura K; Tamamura H
    Bioorg Med Chem Lett; 2016 Jan; 26(2):397-400. PubMed ID: 26706175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A CD4 mimic as an HIV entry inhibitor: pharmacokinetics.
    Hashimoto C; Narumi T; Otsuki H; Hirota Y; Arai H; Yoshimura K; Harada S; Ohashi N; Nomura W; Miura T; Igarashi T; Matsushita S; Tamamura H
    Bioorg Med Chem; 2013 Dec; 21(24):7884-9. PubMed ID: 24189188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small molecular CD4 mimics as HIV entry inhibitors.
    Narumi T; Arai H; Yoshimura K; Harada S; Nomura W; Matsushita S; Tamamura H
    Bioorg Med Chem; 2011 Nov; 19(22):6735-42. PubMed ID: 22014753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4 mimics targeting the HIV entry mechanism and their hybrid molecules with a CXCR4 antagonist.
    Narumi T; Ochiai C; Yoshimura K; Harada S; Tanaka T; Nomura W; Arai H; Ozaki T; Ohashi N; Matsushita S; Tamamura H
    Bioorg Med Chem Lett; 2010 Oct; 20(19):5853-8. PubMed ID: 20728351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small-Molecule CD4 Mimics Containing Mono-cyclohexyl Moieties as HIV Entry Inhibitors.
    Ohashi N; Harada S; Mizuguchi T; Irahara Y; Yamada Y; Kotani M; Nomura W; Matsushita S; Yoshimura K; Tamamura H
    ChemMedChem; 2016 Apr; 11(8):940-6. PubMed ID: 26891461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of N-phenyl-N'-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4.
    Zhao Q; Ma L; Jiang S; Lu H; Liu S; He Y; Strick N; Neamati N; Debnath AK
    Virology; 2005 Sep; 339(2):213-25. PubMed ID: 15996703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4 mimics targeting the mechanism of HIV entry.
    Yamada Y; Ochiai C; Yoshimura K; Tanaka T; Ohashi N; Narumi T; Nomura W; Harada S; Matsushita S; Tamamura H
    Bioorg Med Chem Lett; 2010 Jan; 20(1):354-8. PubMed ID: 19926478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hybrids of Small-Molecule CD4 Mimics with Polyethylene Glycol Units as HIV Entry Inhibitors.
    Kobayakawa T; Tsuji K; Konno K; Himeno A; Masuda A; Yang T; Takahashi K; Ishida Y; Ohashi N; Kuwata T; Matsumoto K; Yoshimura K; Sakawaki H; Miura T; Harada S; Matsushita S; Tamamura H
    J Med Chem; 2021 Feb; 64(3):1481-1496. PubMed ID: 33497209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel small-molecule inhibitor of HIV-1 entry.
    Heredia A; Latinovic OS; Barbault F; de Leeuw EP
    Drug Des Devel Ther; 2015; 9():5469-78. PubMed ID: 26491257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and optimisation of potent gp120-CD4 inhibitors.
    Tran TD; Adam FM; Calo F; Fenwick DR; Fok-Seang J; Gardner I; Hay DA; Perros M; Rawal J; Middleton DS; Parkinson T; Pickford C; Platts M; Randall A; Stephenson PT; Vuong H; Williams DH
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5250-5. PubMed ID: 19632839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of a small molecule inhibitor through interference with the gp120-CD4 interaction.
    Williams DH; Adam F; Fenwick DR; Fok-Seang J; Gardner I; Hay D; Jaiessh R; Middleton DS; Mowbray CE; Parkinson T; Perros M; Pickford C; Platts M; Randall A; Siddle D; Stephenson PT; Tran TD; Vuong H
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5246-9. PubMed ID: 19620004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-Aminothiazolones as anti-HIV agents that act as gp120-CD4 inhibitors.
    Tiberi M; Tintori C; Ceresola ER; Fazi R; Zamperini C; Calandro P; Franchi L; Selvaraj M; Botta L; Sampaolo M; Saita D; Ferrarese R; Clementi M; Canducci F; Botta M
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3043-52. PubMed ID: 24614386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4 mimics as HIV entry inhibitors: lead optimization studies of the aromatic substituents.
    Narumi T; Arai H; Yoshimura K; Harada S; Hirota Y; Ohashi N; Hashimoto C; Nomura W; Matsushita S; Tamamura H
    Bioorg Med Chem; 2013 May; 21(9):2518-26. PubMed ID: 23535561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flexibility of small molecular CD4 mimics as HIV entry inhibitors.
    Kobayakawa T; Ohashi N; Hirota Y; Takahashi K; Yamada Y; Narumi T; Yoshimura K; Matsushita S; Harada S; Tamamura H
    Bioorg Med Chem; 2018 Nov; 26(21):5664-5671. PubMed ID: 30366786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformational changes of gp120 in epitopes near the CCR5 binding site are induced by CD4 and a CD4 miniprotein mimetic.
    Zhang W; Canziani G; Plugariu C; Wyatt R; Sodroski J; Sweet R; Kwong P; Hendrickson W; Chaiken I
    Biochemistry; 1999 Jul; 38(29):9405-16. PubMed ID: 10413516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV entry inhibitors: progress in development and application.
    Lai WH; Huang L; Chen CH
    Yao Xue Xue Bao; 2010 Feb; 45(2):131-40. PubMed ID: 21348414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress in targeting HIV-1 entry.
    Ryser HJ; Flückiger R
    Drug Discov Today; 2005 Aug; 10(16):1085-94. PubMed ID: 16182193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, antiviral activity and resistance of a novel small molecule HIV-1 entry inhibitor.
    Curreli F; Haque K; Xie L; Qiu Q; Xu J; Yong W; Tong X; Debnath AK
    Bioorg Med Chem; 2015 Dec; 23(24):7618-28. PubMed ID: 26602829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and evaluation of potential inhibitors of HIV gp120-CD4 interactions.
    Boussard C; Klimkait T; Mahmood N; Pritchard M; Gilbert IH
    Bioorg Med Chem Lett; 2004 May; 14(10):2673-6. PubMed ID: 15109676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The V1-V3 region of a brain-derived HIV-1 envelope glycoprotein determines macrophage tropism, low CD4 dependence, increased fusogenicity and altered sensitivity to entry inhibitors.
    Rossi F; Querido B; Nimmagadda M; Cocklin S; Navas-Martín S; Martín-García J
    Retrovirology; 2008 Oct; 5():89. PubMed ID: 18837996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.